Bone Biologics Corporation announced that on December 27, 2023 Erick Lucera resigned as a director of the Company, effective upon the appointment of a new director. The resignation was not the result of any disagreement with the Company on any matter relating to the Company?s operations, policies, or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.92 USD | +6.66% | +3.78% | -57.52% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.52% | 1.69M | |
+10.39% | 126B | |
-6.86% | 10.96B | |
+2.52% | 8.97B | |
+38.96% | 5.56B | |
-17.50% | 4.99B | |
+8.36% | 3.44B | |
-8.84% | 2.8B | |
-7.52% | 2.18B | |
-3.00% | 2.16B |
- Stock Market
- Equities
- BBLG Stock
- News Bone Biologics Corporation
- Bone Biologics Corporation Announces the Resignation of Erick Lucera as Director